Differential tear metabolomics in blepharokeratoconjunctivitis and herpes simplex keratitis: potential biomarkers for clinical differentiation - Summary - MDSpire

Differential tear metabolomics in blepharokeratoconjunctivitis and herpes simplex keratitis: potential biomarkers for clinical differentiation

  • By

  • Zi-wen Wang

  • Zhen-ning Wu

  • Hui-zhen Wang

  • Shi-you Zhou

  • July 15, 2026

Share

Objective:

To characterize tear metabolomic differences between active blepharokeratoconjunctivitis (BKC) and herpes simplex keratitis (HSK; epithelial type) and identify diagnostic biomarkers.

Approach:
  • Patient Enrollment: Tear samples were collected from 24 HSK patients, 19 BKC patients, and 15 healthy controls from October 2020 to 2021.
  • Metabolomic Profiling: Metabolomic profiling was performed via LC-MS/MS, and data were analyzed using MetaboAnalyst 5.0.
Key Findings:
  • HSK exhibited 21 altered metabolites compared to healthy controls.
  • BKC showed 19 altered metabolites compared to healthy controls.
  • L-isoleucine, L-phenylalanine, and pantothenol were significantly lower in both HSK and BKC after FDR correction.
  • 4-dodecylbenzenesulfonic acid and carnosol were lower in HSK-specific samples.
  • Sorbitol was lower in BKC-specific samples.
  • A combined panel of metabolites (4-dodecylbenzenesulfonic acid, carnosol, sorbitol) showed good specificity and sensitivity for differentiating BKC from HSK.
Interpretation:

Limitations:
  • Study conducted at a single center with a limited sample size.
  • Potential confounding factors not fully explored.
Conclusion:

Original Source(s)

Related Content